440 A hospital's effort to lower the readmission of patients with heart failure (help-hf): a pilot study

Wednesday, October 24, 2012
Westin Diplomat Resort
Pamela M. Moye, PharmD, BCPS1, Paul Douglass, MD2, Phillip S. Owen, PharmD, BCPS1 and Teresa Pounds, PharmD, BCNSP2
1Mercer University College of Pharmacy and Health Sciences, Atlanta, GA
2Atlanta Medical Center, Atlanta, GA

Purpose: This study was designed to evaluate if a pharmacist-lead education intervention program would aid in the decrease of hospital re-admissions in heart failure patients at an urban community teaching hospital.

Methods: Patients were randomized into an intervention and control group. Those included in study were admitted to Atlanta Medical Center from August 1, 2011 to January 30, 2012 with a primary or secondary diagnosis of heart-failure as identified by the daily Evidenced Based Medicine report. The control group received standard of care. The intervention included one-on-one medicaton/disease management discharge counseling from a pharmacist, patients were given individualized information regarding their disease state, patients were called on days 14 and 28 post discharge.

Results: 60 patients (control n=38, intervention n= 22) were included in the study. The 30 day readmission rates for the control group and intervention group was 21% and 9.5%, respectively. The baseline characteristics were similar between the groups which included: ejection fraction, length of hospital stay, and co-morbidities.

Conclusion: The patients in the intervention group 30 day readmission rates were approximately 50% less than the patients in the control group. This suggests that a pharmacist supported intervention program may aid in decreasing 30 day readmissions in patients with heart failure.